Ovid Therapeutics (OVID) stock: insider trades, news & valuation
Net sellingShare price and insider trades
Ovid Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $29K of OVID stock on the open market.
Get emailed when insiders cluster-buy stocks like OVID
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
OVID insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $29K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Ovid Therapeutics Inc. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $29K. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 2SEC | Margaret A. AlexanderCEO, President | Sell | 11,65661,750 held (−16%) | $1.45 | $17K | +69.7% | — |
| Mar 2SEC | Jeffrey A RonaCbfo | Sell | 8,54188,188 held (−9%) | $1.45 | $12K | +69.7% | — |
Insiders at Ovid Therapeutics Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Margaret A. AlexanderCEO, President | — | $17K | Mar 2, 2026 | — |
| Jeffrey A RonaCbfo | — | $12K | Mar 2, 2026 | — |
OVID stock: common questions
Are Ovid Therapeutics Inc. insiders buying OVID stock?
In the past 12 months, 0 insiders reported open-market purchases of OVID worth $0.
Are Ovid Therapeutics Inc. insiders selling OVID stock?
2 insiders reported sales worth $29K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is OVID's 52-week range?
Over the past year OVID has traded between $1.20 and $2.96. It last closed at $2.46 on Oct 9, 2026.